Altered gene expression due to aberrant DNA methylation correlates with responsiveness to anti‐EGFR antibody treatment

por Otsuki, Yasufumi, Ouchi, Kota, Takahashi, Shin, Sasaki, Keiju, Sakamoto, Yasuhiro, Okita, Akira, Ishioka, Chikashi
Publicado 2022

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

por Okita, Akira, Takahashi, Shin, Ouchi, Kota, Inoue, Masahiro, Watanabe, Mika, Endo, Mareyuki, Honda, Hiroshi, Yamada, Yasuhide, Ishioka, Chikashi
Publicado 2018

A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer

por Ouchi, Kota, Takahashi, Shin, Okita, Akira, Sakamoto, Yasuhiro, Muto, Osamu, Amagai, Kenji, Okada, Takaho, Ohori, Hisatsugu, Shinozaki, Eiji, Ishioka, Chikashi
Publicado 2022

Antibiotic therapy augments the efficacy of gemcitabine-containing regimens for advanced cancer: a retrospective study

por Imai, Hiroo, Saijo, Ken, Komine, Keigo, Otsuki, Yasufumi, Ohuchi, Kota, Sato, Yuko, Okita, Akira, Takahashi, Masahiro, Takahashi, Shin, Shirota, Hidekazu, Takahashi, Masanobu, Ishioka, Chikashi
Publicado 2019

The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study

por Takahashi, Masahiro, Takahashi, Masanobu, Komine, Keigo, Yamada, Hideharu, Kasahara, Yuki, Chikamatsu, Sonoko, Okita, Akira, Ito, Shukuei, Ouchi, Kota, Okada, Yoshinari, Imai, Hiroo, Saijo, Ken, Shirota, Hidekazu, Takahashi, Shin, Mori, Takahiro, Shimodaira, Hideki, Ishioka, Chikashi
Publicado 2017

Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors

por Ouchi, Kota, Takahashi, Shin, Chikamatsu, Sonoko, Ito, Shukuei, Takahashi, Yoshikazu, Kawai, Sadayuki, Okita, Akira, Kasahara, Yuki, Okada, Yoshinari, Imai, Hiroo, Komine, Keigo, Saijo, Ken, Takahashi, Masahiro, Shirota, Hidekazu, Takahashi, Masanobu, Gamoh, Makio, Ishioka, Chikashi
Publicado 2018

Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer

por Takahashi, Shin, Sakamoto, Yasuhiro, Denda, Tadamichi, Takashima, Atsuo, Komatsu, Yoshito, Nakamura, Masato, Ohori, Hisatsugu, Yamaguchi, Tatsuro, Kobayashi, Yoshimitsu, Baba, Hideo, Kotake, Masanori, Amagai, Kenji, Kondo, Hitoshi, Shimada, Ken, Sato, Atsushi, Yuki, Satoshi, Okita, Akira, Ouchi, Kota, Komine, Keigo, Watanabe, Mika, Morita, Satoshi, Ishioka, Chikashi
Publicado 2021

Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methyl...

por Takahashi, Shin, Ouchi, Kota, Sakamoto, Yasuhiro, Mori, Takahiro, Shimodaira, Hideki, Takahashi, Masahiro, Ohori, Hisatsugu, Kudo, Chieko, Takahashi, Yoshikazu, Imai, Hiroo, Akiyama, Shoko, Takahashi, Masanobu, Suto, Takeshi, Murakawa, Yasuko, Oishi, Takayuki, Isobe, Hideki, Okada, Yoshinari, Kawai, Sadayuki, Yoshioka, Takashi, Sato, Toshihiko, Shindo, Yoshiaki, Sugiyama, Shunsuke, Komine, Keigo, Chiba, Natsuko, Okita, Akira, Yamaguchi, Takuhiro, Ishioka, Chikashi
Publicado 2023